Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18,466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study.
Pasic I, Moya TA, Remberger M, Chen C, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J. Pasic I, et al. Among authors: kumar r. Transplant Cell Ther. 2024 Apr 20:S2666-6367(24)00367-1. doi: 10.1016/j.jtct.2024.04.014. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38648898
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies.
Law AD, Salas MQ, Lam W, Michelis FV, Thyagu S, Kim DDH, Lipton JH, Kumar R, Messner H, Viswabandya A. Law AD, et al. Among authors: kumar r. Biol Blood Marrow Transplant. 2018 Nov;24(11):2259-2264. doi: 10.1016/j.bbmt.2018.07.008. Epub 2018 Aug 7. Biol Blood Marrow Transplant. 2018. PMID: 30009980 Free PMC article.
Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease.
Shapiro RM, Shin E, Law AD, Lam W, Michelis FV, Viswabandya A, Kumar R, Lipton JH, Messner H, Mattsson J, Kim DDH. Shapiro RM, et al. Among authors: kumar r. Biol Blood Marrow Transplant. 2019 Sep;25(9):1761-1769. doi: 10.1016/j.bbmt.2019.05.029. Epub 2019 Jun 4. Biol Blood Marrow Transplant. 2019. PMID: 31170520 Free article. Clinical Trial.
Impressive Graft-versus-Host Disease-Free, Relapse-Free Survival in Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning and a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide.
Salas MQ, Kumar R, Viswabandya A. Salas MQ, et al. Among authors: kumar r. Biol Blood Marrow Transplant. 2019 Nov;25(11):e352-e353. doi: 10.1016/j.bbmt.2019.07.005. Epub 2019 Jul 4. Biol Blood Marrow Transplant. 2019. PMID: 31279750 Free article. No abstract available.
18,466 results
You have reached the last available page of results. Please see the User Guide for more information.